Both in Pharmaceuticals
CytomX Therapeutics vs Shattuck Labs
Over the past year CTMX returned −31.9% and STTK returned +179.0%; their daily moves had a correlation of 0.23.
CTMX −31.9% STTK +179.0%Growth of $1, one year, split-adjusted
| Metric | CTMX | STTK |
|---|---|---|
| Price | $2.26 | $5.58 |
| Market cap | $492.5M | $560.0M |
| Today | −4.24% | −3.88% |
| 1 month | −16.9% | −18.2% |
| 6 months | −46.4% | −22.0% |
| Year to date | −46.9% | +52.9% |
| 1 year | −31.9% | +179.0% |
| Revenue growth (YoY) | −92.4% | — |
| Gross margin | 100.0% | — |
| Net margin | −1457.4% | — |
| P/E (TTM) | — | — |
| Price / sales | 26.9× | 560.0× |
| Net cash | $330.3M | $208.3M |
| Dividend yield | — | — |
| Volatility (60d) | 67.4% | 58.2% |
| Short % of float | 21.4% | 13.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).